Nutrien (NTR) Earnings Date & Reports

Nutrien posted Q1 2026 sales of $6.05 billion, surpassing consensus estimates of approximately $5.3 billion and up 19% from $5.1 billion in Q1 2025. Gross margin improved 25% to $1.65 billion. Adjusted EBITDA climbed 30% to $1.11 billion, reflecting higher net selling prices across segments and record upstream volumes. Adjusted net EPS was $0.51, beating analyst expectations of $0.48-$0.54, while diluted EPS reached $0.27 (up from $0.02 year-over-year).

Segment highlights included:

• Retail: Sales $3.64 billion (+18% YoY), adjusted EBITDA $108 million (up 135% from $46 million), fueled by higher crop nutrient volumes (2.45 million tonnes) and proprietary product margins.
• Potash: Net sales $926 million (+24%), adjusted EBITDA $578 million (+30% from $446 million), record sales volumes of 3.51 million tonnes.
• Nitrogen: Net sales $1.01 billion (+15%), adjusted EBITDA $482 million (+19% from $405 million), sales volumes 2.34 million tonnes, ammonia rate 92%.
• Phosphate: Net sales $485 million (+35%), adjusted EBITDA $57 million (down 7% from $61 million due to higher sulfur costs), volumes 0.66 million tonnes.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore it today to enhance your research process.

Market Reaction and Investor Sentiment

Post-earnings, NTR shares traded lower in initial reaction, reflecting mixed interpretations despite the beat. Potash record volumes and EBITDA growth were positives, but Phosphate margin pressure from input costs tempered enthusiasm. Pre-earnings upgrades from firms like BofA and Barclays signaled optimism on supply disruptions boosting prices, yet sentiment remains cautious amid cyclical risks. Options activity showed elevated volume, with investors positioning for volatility around guidance reaffirmation.

Forward Outlook and Key Factors to Monitor

Nutrien reaffirmed its 2026 guidance, targeting potash sales volumes of 14.1-14.8 million tonnes, nitrogen 9.2-9.7 million tonnes, and phosphate 2.4-2.6 million tonnes. Retail adjusted EBITDA is pegged at $1.75-$1.95 billion, assuming mid-single-digit crop nutrient volume growth and high-single-digit proprietary margins expansion.

Investors should watch global potash demand, projected at 74-77 million tonnes amid soil replenishment needs post-2025 bumper crops. Nitrogen benefits from tight supply and Asian/Latin American growth, while phosphate faces farmer cutbacks but higher benchmarks. Controllable potash costs remain below $60/tonne, supporting margins.

Strategic reviews continue for phosphate business, Trinidad nitrogen facility, and Brazilian retail to optimize portfolio and boost free cash flow. Capital expenditures stay at $2.0-$2.1 billion, with $409 million already returned to shareholders this quarter via dividends ($0.55/share) and buybacks. Broader catalysts include fertilizer price trends, weather impacts on planting, and geopolitical supply risks like Middle East tensions affecting energy costs.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations